84 related articles for article (PubMed ID: 21348868)
1. Novel glucokinase mutations in patients with monogenic diabetes - clinical outline of GCK-MD and potential for founder effect in Slavic population.
Borowiec M; Antosik K; Fendler W; Deja G; Jarosz-Chobot P; Mysliwiec M; Zmyslowska A; Malecki M; Szadkowska A; Mlynarski W
Clin Genet; 2012 Mar; 81(3):278-83. PubMed ID: 21348868
[TBL] [Abstract][Full Text] [Related]
2. Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients.
Garin I; Rica I; Estalella I; Oyarzabal M; Rodríguez-Rigual M; San Pedro JI; Pérez-Nanclares G; Fernández-Rebollo E; Busturia MA; Castaño L; Pérez de Nanclares G;
Clin Endocrinol (Oxf); 2008 Jun; 68(6):873-8. PubMed ID: 18248649
[TBL] [Abstract][Full Text] [Related]
3. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene.
Bennett K; James C; Mutair A; Al-Shaikh H; Sinani A; Hussain K
Pediatr Diabetes; 2011 May; 12(3 Pt 1):192-6. PubMed ID: 21518409
[TBL] [Abstract][Full Text] [Related]
4. Ancestral mutations may cause a significant proportion of GCK-MODY.
Dusatkova P; Pruhova S; Borowiec M; Vesela K; Antosik K; Lebl J; Mlynarski W; Cinek O
Pediatr Diabetes; 2012 Sep; 13(6):489-98. PubMed ID: 22332836
[TBL] [Abstract][Full Text] [Related]
5. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
6. MODY type 2 P59S GCK mutant: founder effect in South of Italy.
Delvecchio M; Ludovico O; Bellacchio E; Stallone R; Palladino T; Mastroianno S; Zelante L; Sacco M; Trischitta V; Carella M
Clin Genet; 2013 Jan; 83(1):83-7. PubMed ID: 22335469
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
[TBL] [Abstract][Full Text] [Related]
8. [Mutation screening of GCK gene in Chinese early-onset diabetes population].
Zheng TS; Wu SH; Yang Z; Lu HJ; Xiang KS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):671-4. PubMed ID: 16331569
[TBL] [Abstract][Full Text] [Related]
9. Glucokinase gene mutation screening in Argentinean clinically characterized MODY patients.
Lopez AP; Foscaldi SA; Pérez MS; Krochik G; Rodríguez M; Traversa M; Puchulu FM; Hirschler V; Bergada I; Frechtel GD
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):391-4. PubMed ID: 19358091
[TBL] [Abstract][Full Text] [Related]
10. A novel nonsense mutation in GCK exon 9 co-segregates with diabetes phenotype.
Knebel B; Jacob S; Boxberg CV; Müller-Wieland D; Kotzka J
Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):298-301. PubMed ID: 15216446
[TBL] [Abstract][Full Text] [Related]
11. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
12. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
Turkkahraman D; Bircan I; Tribble ND; Akçurin S; Ellard S; Gloyn AL
J Pediatr; 2008 Jul; 153(1):122-6. PubMed ID: 18571549
[TBL] [Abstract][Full Text] [Related]
13. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
[TBL] [Abstract][Full Text] [Related]
14. Three novel mutations in MODY and its phenotype in three different Czech families.
Bazalová Z; Rypácková B; Broz J; Brunerová L; Polák J; Rusavý Z; Treslová L; Andel M
Diabetes Res Clin Pract; 2010 May; 88(2):132-8. PubMed ID: 20132997
[TBL] [Abstract][Full Text] [Related]
15. Association of a homozygous GCK missense mutation with mild diabetes.
Marucci A; Biagini T; Di Paola R; Menzaghi C; Fini G; Castellana S; Cardinale GM; Mazza T; Trischitta V
Mol Genet Genomic Med; 2019 Jul; 7(7):e00728. PubMed ID: 31197960
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY).
McKinney JL; Cao H; Robinson JF; Metzger DL; Cummings E; Riddell DC; Sanderson SR; Pacaud D; Ho J; Hegele RA
Clin Invest Med; 2004 Jun; 27(3):135-41. PubMed ID: 15305805
[TBL] [Abstract][Full Text] [Related]
17. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young.
Mantovani V; Salardi S; Cerreta V; Bastia D; Cenci M; Ragni L; Zucchini S; Parente R; Cicognani A
Hum Mutat; 2003 Oct; 22(4):338. PubMed ID: 12955723
[TBL] [Abstract][Full Text] [Related]
18. Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene.
Borowiec M; Mysliwiec M; Fendler W; Antosik K; Brandt A; Malecki M; Mlynarski W
Acta Diabetol; 2011 Sep; 48(3):203-8. PubMed ID: 21437567
[TBL] [Abstract][Full Text] [Related]
19. Who should have genetic testing for maturity-onset diabetes of the young?
Naylor R; Philipson LH
Clin Endocrinol (Oxf); 2011 Oct; 75(4):422-6. PubMed ID: 21521318
[TBL] [Abstract][Full Text] [Related]
20. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.
Rica I; Luzuriaga C; Pérez de Nanclares G; Estalella I; Aragonés A; Barrio R; Bilbao JR; Carlés C; Fernández C; Fernández JM; Fernández-Rebollo E; Gastaldo E; Giralt P; Gomez Vida JM; Gutiérrez A; López Siguero JP; Martínez-Aedo MJ; Muñoz M; Prieto J; Rodrigo J; Vargas F; Castano L
Diabet Med; 2007 Jul; 24(7):707-13. PubMed ID: 17490422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
